Evox Therapeutics is a biotechnology company.
Evox Therapeutics has raised €82M across 2 funding rounds from 2 investors, most recently a Series C round in Feb 2021. Based in Oxford, UK; founded 2016; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-02-19 | Series C | €80M | Redmile Group | View deal → |
| 2019-01-01 | Other | €1.7M | Innovate UK | View deal → |
